Use access key #2 to skip to page content.
$6.93 1.73 (33.27%)
10/6/2008 4:00 PM

Dendreon Corp (DNDN)

CAPS Rating:
**

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.

View All Commentary (DNDN)

Recs

2

Avatar tharlow (76.20) Submitted: 8/14/07 12:36 AM : Underperform Start Price: $7.33 DNDN Score: -22.67

The ultimate placebo. Sugar tablets have never been so high-tech.

Report this Post Replies: 0 | Reply

Featured Broker Partners